{"name":"Pherin Pharmaceuticals, Inc.","slug":"pherin-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"PH80","genericName":"PH80","slug":"ph80","indication":"Social anxiety disorder","status":"phase_3"}]}],"pipeline":[{"name":"PH80","genericName":"PH80","slug":"ph80","phase":"phase_3","mechanism":"PH80 is a pheromone-based therapeutic designed to modulate human behavior and physiological responses through olfactory signaling.","indications":["Social anxiety disorder","Autism spectrum disorder (social communication deficits)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitgJBVV95cUxOd0p6eTU0bHJFbDFqSV84R1BRcm01TF8yVlplZnE3VVE2dTJKOHR5ZFdOLWlKT2ZnbHlfdlBMNm9lVXVmMnBpejd2ajRxeEhhQk1CRHNPZE5GQ1VaYUJmanNuME5idFhJaW9BbnhmR0haTFRjWXZ3MlpKQ25EVnNHMVAyc0VWT2VubnN1SnpLRXliUGZLNFpfZGU1MEt5akluVTVZOTdpTHZXRjVobnVicVU3TGNIeTFoa0Z2azBYM0txclRDZVhDOFNkNTEtcE9ZREVFVW5xZ1JhV3lTVnZxRXNsQ3huZi15ZUEyS1dHcnIzZWlOX0hIZ0hCMGRLdWl6U01PcmZZcG1FLWhneWVGQzdtSmdlVk1PLUVrRlcxc1BRT2dmRFFHekN6TGlXYlZ3VzBRd3Vn?oc=5","date":"2025-01-22","type":"trial","source":"globenewswire.com","summary":"5-HT2 Agonist Clinical Trial Pipeline Appears Robust With - globenewswire.com","headline":"5-HT2 Agonist Clinical Trial Pipeline Appears Robust With","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxPM3JGMXZLMi1ST0VjUE9HZlVUZ1FFM0d4djJOaXkzZ0NpWEQ3SjNKOGlXQzN2c2premswUm9xNmlQOXFGcUlkN0lUaWhDS0VrNE1Kd2VzYzM0bkJwVU5VM3B1VWFwdmtrcUtkTkd3d28xTlprWVYzUHZxTllNcy1zRTQzTjR4LTdtVlFXMGpaM1QxU3pRTXJnNEpyb0pOOEZ6NWRhVkZocWo1LVpQODhhZ3ZXNmlIajEwVDdQOUlrcVFMdlkwdUtBZVFkYVlURnJCQjVsTFp2dTdwd3FWN3dxS2VIaUFOd0lfd05MbDM0blZ6VEEtcDFB?oc=5","date":"2024-11-25","type":"pipeline","source":"PR Newswire","summary":"Major Depressive Disorder Market to Register Immense Growth by 2034 Owing to a Robust Pipeline | DelveInsight - PR Newswire","headline":"Major Depressive Disorder Market to Register Immense Growth by 2034 Owing to a Robust Pipeline | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxPZ3JtZ1NSd2lzV3NKcVdzU3NMYy1hZDh3anB3VmgxRS04aEpBRlQwNjRDMF94QkoyZ3dBVnpURWI5aWlXSVZCMGhseDA4akhkeHNCaENHTkk0M3pqc2FlMlBzazFXVDhiLWdFMGk4dzJrUWgxYkNONC12UDdSUzRBZ0RyWkRET0k2YTJSTjVTTUwyY3A3TEp5dzNUX052c1YxRHVBSXd0aWpfUmlOQTNHY2J5dThGbjBRS01zZWpxdzUwelVhWmN0WWdyWjk2dGVBeGlUc2Ffb1h3eHlaelh5bWEtRHNVdktSUjNldU9n?oc=5","date":"2024-09-26","type":"pipeline","source":"PR Newswire","summary":"Global Hormone Replacement Therapy Market to Grow Substantially at a CAGR of ~6% by 2030 | DelveInsight - PR Newswire","headline":"Global Hormone Replacement Therapy Market to Grow Substantially at a CAGR of ~6% by 2030 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNeTVaczEwcXhNMXFrQVB4LTE2WEpYN3BzRHdJODVqX0ZXR2l5ZUdGTnBKVlNMT09mQl8wYUtSODNzbFVRdUNxNzFTT2Z1REN1V2JFLUpvZ2RZRHRvb2wzNTY3MnUzTHh0aUl4TGRXRUhVMXE4UGxVbTY2LWRKM1FmOW92OEZSRWpJ?oc=5","date":"2024-04-16","type":"pipeline","source":"Yahoo Finance","summary":"Global Anti-Depressant Drugs Market to Register Incremental Growth by 2030, Predicts DelveInsight | Key Companies - AbbVie, AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, H. Lundbeck AS, Johnson","headline":"Global Anti-Depressant Drugs Market to Register Incremental Growth by 2030, Predicts DelveInsight | Key Companies - AbbV","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxOVGRoV09VTzZIWmE5X09Sb3F5bkp1R1Y0RGtEbUEwZ250RFhrcnRuYTJOQjczZGU5YV9GMURPNW95bzBvMHlKSDFGUXpWalZoWWtpS1NmU1hJNVhuVkh2X3ZNb3J2NnNQU3pKUUFMRUVCc1QxRlNhRWtQWTdnS0FsZ1hnMnNsay1mVjNJeTVsX1lhcEs2UU9ORzhMOE9sSnR2TkFIcDBYM3lYdVJaM0RiNURRMnQ?oc=5","date":"2022-12-21","type":"deal","source":"drugdiscoverytrends.com","summary":"Vistagen acquires Pherin Pharmaceuticals for its neuroactive steroid pipeline - drugdiscoverytrends.com","headline":"Vistagen acquires Pherin Pharmaceuticals for its neuroactive steroid pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQemxjZmY3dFFqYnRCWEdhV2VBVWpOMVJNMEVxWWl1M2FYVmdPZEVJUDJoXzl1VjMzZ3I3Um9NeWlYeTl5cFFoM2ZuVFVMb2cyLVhhaXlYRVM0YlRUamJURFBIem9PWDNrNU5qYTduc1dMcWxTMHd6bUl5ZTVscEF2anFidnRnZ0hyVnR3ejBwNHpvSUNRQVk1TFd2Z0cxa0dSWDF2RG5KUldPbDRjZUNiUjFKbERjYmhVcFdDel91UVlrQQ?oc=5","date":"2022-12-21","type":"deal","source":"Fierce Biotech","summary":"Vistagen buys out Pherin more than 4 years after licensing now-lead social anxiety spray - Fierce Biotech","headline":"Vistagen buys out Pherin more than 4 years after licensing now-lead social anxiety spray","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPYkF2RENvTXFwWmxJRS11MmZwa3VmWmlEbkJSMjJnd2czam5JZlk0akY3ODJveFlSbVlwbTJHTzVxc21yMFlxLTRnZFRwSnVWYl9RTmlKdWJ6cDJDZlhHcEQzNldPcFdTT3BmWGhmejJVNzhlbktIOWg4U1R3VkVCbXR1U0cyN3h6M0ljd0dpek9SR0k5bF9UZXhWdkU?oc=5","date":"2018-09-13","type":"trial","source":"Fierce Biotech","summary":"VistaGen nabs phase 3-ready social anxiety drug from Pherin - Fierce Biotech","headline":"VistaGen nabs phase 3-ready social anxiety drug from Pherin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPcGVYeWpfam9QMXV5RmxtRzVDRmN1dlJLaElmeGx2VEV3cXpqSUVnRjVhclVpSDVGQUpkdnZEakc3aElMR004aV9sVkZpNWx3TEJRcVJiMjFUck5sQUNfNU5yM3JDdlp3MDNPeEd3dWhhTE9xSExKZEM0VGxtWTFQd3Z2ZEZDYkVXeUNLcFB0MzRieHRuVEViLTkzZmtNbUFXZzVBTWpR?oc=5","date":"2016-08-04","type":"pipeline","source":"The Pharmaceutical Journal","summary":"Anxiety drugs: stressing the importance of innovation - The Pharmaceutical Journal","headline":"Anxiety drugs: stressing the importance of innovation","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}